41886-04-8 Usage
Uses
Used in Pharmaceutical Industry:
3-(bromomethyl)-1-methylpiperidine(SALTDATA: HBr) is used as a building block for the synthesis of various biologically active molecules, such as pharmaceutical compounds. Its reactive bromomethyl group allows for the formation of new chemical bonds, facilitating the creation of diverse drug candidates with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 3-(bromomethyl)-1-methylpiperidine(SALTDATA: HBr) serves as a precursor for the synthesis of agrochemicals, including pesticides and herbicides. Its reactivity and structural features enable the development of novel compounds with improved efficacy and selectivity in controlling pests and weeds.
Used in Research Laboratories:
3-(bromomethyl)-1-methylpiperidine(SALTDATA: HBr) is utilized in research laboratories as a precursor in the preparation of other organic compounds. Its unique structure and reactivity make it a valuable tool for exploring new synthetic pathways and developing innovative chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 41886-04-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,8,8 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 41886-04:
(7*4)+(6*1)+(5*8)+(4*8)+(3*6)+(2*0)+(1*4)=128
128 % 10 = 8
So 41886-04-8 is a valid CAS Registry Number.
41886-04-8Relevant academic research and scientific papers
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
-
, (2008/06/13)
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS
-
Page 108, (2008/06/13)
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
